Published in Annu Rev Microbiol on January 01, 1982
Translation and processing of mouse hepatitis virus virion RNA in a cell-free system. J Virol (1986) 1.51
Natural products for cancer chemotherapy. Microb Biotechnol (2010) 1.45
Degradation of the Major Storage Protein of Phaseolus vulgaris during Germination : Role of Endogenous Proteases and Protease Inhibitors. Plant Physiol (1984) 1.44
From natural products discovery to commercialization: a success story. J Ind Microbiol Biotechnol (2006) 1.07
A sensitive diffusion plate assay for screening inhibitors of protease activity in plant cell fractions. Plant Physiol (1986) 1.04
Enthalpy array analysis of enzymatic and binding reactions. Anal Biochem (2008) 1.03
A novel member of the subtilisin-like protease family from Streptomyces albogriseolus. J Bacteriol (1997) 0.95
Adeno-associated virus capsid antigen presentation is dependent on endosomal escape. J Clin Invest (2013) 0.92
Purification and characterization of pentagalloylglucose, and alpha-glucosidase inhibitor/antibiotic from the freshwater green alga Spirogyra varians. Biochem J (1988) 0.92
Measurement of enzyme kinetics and inhibitor constants using enthalpy arrays. Anal Biochem (2009) 0.90
Two crystal structures of the leupeptin-trypsin complex. Protein Sci (1996) 0.90
Control of RecBCD enzyme activity by DNA binding- and Chi hotspot-dependent conformational changes. J Mol Biol (2014) 0.86
Characterization of the active site of human multicatalytic proteinase. Biochem J (1990) 0.85
Epitopes shared by unrelated antigens of Borrelia burgdorferi. Infect Immun (1994) 0.85
Cathepsins L and Z are critical in degrading polyglutamine-containing proteins within lysosomes. J Biol Chem (2012) 0.80
Streptomyces serine protease (SAM-P20): recombinant production, characterization, and interaction with endogenous protease inhibitor. J Bacteriol (1995) 0.80
A pepstatin-insensitive aspartic proteinase from a thermophilic Bacillus sp. Biochem J (1995) 0.80
Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway. Immunology (2006) 0.79
Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PLoS One (2014) 0.78
The effect of synthetic analogues of chymostatin upon protein degradation in isolated skeletal muscle. Biochem J (1985) 0.77
Structural and enzymatic characterization of a host-specificity determinant from Salmonella. Acta Crystallogr D Biol Crystallogr (2014) 0.77
Transmission of electrical signals by spin-wave interconversion in a magnetic insulator. Nature (2010) 4.10
New antibiotics, bleomycin A and B. J Antibiot (Tokyo) (1966) 3.58
Formation and reversion of Streptomycete protoplasts: cultural condition and morphological study. J Gen Microbiol (1974) 3.56
Spin Seebeck insulator. Nat Mater (2010) 3.01
Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli. J Antibiot (Tokyo) (1967) 2.60
3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) (1971) 2.60
Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor. Science (1967) 2.55
Pepstatin, a new pepsin inhibitor produced by Actinomycetes. J Antibiot (Tokyo) (1970) 2.52
Inhibition of DNA-dependent RNA synthesis by rifamycins. J Antibiot (Tokyo) (1968) 2.41
Adenylylstreptomycin, a product of streptomycin inactivated by E. coli carrying R factor. J Antibiot (Tokyo) (1968) 2.19
Letter: Two beta-lactamase inhibitors produced by a streptomyces. J Antibiot (Tokyo) (1973) 2.16
Structures and activities of protease inhibitors of microbial origin. Methods Enzymol (1976) 2.03
Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol (1986) 1.87
Isolation of kanamycin and paromamine inactivated by E. coli carrying R factor. J Antibiot (Tokyo) (1968) 1.85
Inhibition of DNA-dependent RNA polymerase reaction of Escherichia coli by an antimicrobial antibiotic, streptovaricin. Biochim Biophys Acta (1968) 1.81
On the mechanism of action of bleomycin: scission of DNA strands in vitro and in vivo. J Antibiot (Tokyo) (1969) 1.80
Effect of pepstatin on acid proteases. J Antibiot (Tokyo) (1971) 1.75
Studies on inactivation of kanamycin and resistances of E. coli. J Antibiot (Tokyo) (1967) 1.67
Studies on adenylylstreptomycin, a product of streptomycin inactivation by E. coli carrying the R-factor. J Antibiot (Tokyo) (1968) 1.66
Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot (Tokyo) (1976) 1.66
R factor-mediated aminoglycoside antibiotic resistance in Pseudomonas aeruginosa: a new aminoglycoside 6'-N-acetyltransferase. Antimicrob Agents Chemother (1975) 1.61
Phosphorylation and inactivation of aminoglycosidic antibiotics by E. coli carrying R factor. J Antibiot (Tokyo) (1968) 1.58
Letter: A thermolysin inhibitor produced by Actinomycetes: phospholamidon. J Antibiot (Tokyo) (1973) 1.50
Bleomycin and other antitumor antibiotics of high molecular weight. Antimicrob Agents Chemother (Bethesda) (1965) 1.49
Studies on bleomycin. Cancer (1967) 1.49
Letter: Kanamycin phosphotransferase. I. Mechanism of cross resistance between kanamycin and lividomycin. J Antibiot (Tokyo) (1973) 1.44
Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa. Appl Microbiol (1968) 1.43
Phosphorylation and inactivation of kanamycin by Pseudomonas aeruginosa. J Antibiot (Tokyo) (1968) 1.38
Chemistry and mechanism of action of bleomycin. Fed Proc (1974) 1.38
Activity and toxicity of bleomycin. J Antibiot (Tokyo) (1967) 1.35
Inactivation and phosphorylation of kanamycin by drug-resistant Staphylococcus aureus. Appl Microbiol (1968) 1.35
Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes. Cancer Res (1972) 1.34
Inhibition of initiation of DNA-dependent RNA synthesis by an antibiotic B44p. Biochem Biophys Res Commun (1968) 1.28
Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria. J Antibiot (Tokyo) (1973) 1.28
Effect of bleomycin on mammalian cell survival. J Natl Cancer Inst (1972) 1.24
Letter: Gentamicin acetyltransferase in Escherichia coli carrying R factor. J Antibiot (Tokyo) (1973) 1.23
Antipain, a new protease inhibitor isolated from actinomycetes. J Antibiot (Tokyo) (1972) 1.21
Aminoglycoside 3'-phosphotransferase III, a new phosphotransferase. Resistance mechanism. J Antibiot (Tokyo) (1975) 1.19
Effect of protease inhibitors of actinomycetes on lysosomal peptide-hydrolases from swine liver. J Antibiot (Tokyo) (1971) 1.19
Biological studies on bleomycin A. J Antibiot (Tokyo) (1967) 1.18
[Preferential inhibition of the growth of Escherichia coli strains carrying episomes]. J Antibiot (Tokyo) (1970) 1.17
Structures of new antibiotics napyradiomycins. J Antibiot (Tokyo) (1986) 1.16
Biosynthesis of napyradiomycins. J Antibiot (Tokyo) (1987) 1.16
The structure of pepstatin. J Antibiot (Tokyo) (1970) 1.15
Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn J Cancer Res (1985) 1.15
6'-N-acetylation of 3',4'-dideoxykanamycin B by an enzyme in a resistant strain of Pseudomonas aeruginosa. J Antibiot (Tokyo) (1972) 1.13
Studies on formycin and formycin B in cells of Ehrlich carcinoma and E. coli. J Antibiot (Tokyo) (1967) 1.12
Aminoglycoside 3'-phosphotransferases I and II in Pseudomonas aeruginosa. J Antibiot (Tokyo) (1975) 1.11
A plasmid involved in chloramphenicol production in Streptomyces venezuelae: evidence from genetic mapping. J Gen Microbiol (1975) 1.10
Structure determinations of enzymatically phosphorylated products of aminoglycosidic antibiotics by proton magnetic resonance. J Antibiot (Tokyo) (1971) 1.10
Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes. J Antibiot (Tokyo) (1970) 1.10
Mode of inhibition of coformycin on adenosine deaminase. J Antibiot (Tokyo) (1967) 1.10
Modes of action of phleomycin, bleomycin and formycin on HeLa S3 cells in synchronized culture. J Antibiot (Tokyo) (1967) 1.07
An evaluation of taxonomic criteria in streptomycetes on the basis of deoxyribonucleic acid homology. J Gen Microbiol (1972) 1.06
Possible control of formation of aerial mycelium and antibiotic production in Streptomyces by episomic factors. J Antibiot (Tokyo) (1970) 1.06
Prolongation of rat heart allograft survival by 15-deoxyspergualin. J Antibiot (Tokyo) (1987) 1.05
Isolation and characterization of lividomycin A inactivated by Pseudomonas aeruginosa and Escherichia coli carrying R factor. J Antibiot (Tokyo) (1972) 1.05
Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes. J Antibiot (Tokyo) (1985) 1.04
A new antitumor antibiotic, spergualin: isolation and antitumor activity. J Antibiot (Tokyo) (1981) 1.04
Pyruvate kinase of Escherichia coli. Its role in supplying nucleoside triphosphates in cells under anaerobic conditions. J Biochem (1974) 1.03
Bottromycin A1, A2 and their structures. J Antibiot (Tokyo) (1966) 1.03
Biosynthetic studies of terpentecin. J Antibiot (Tokyo) (1986) 1.03
Amastatin, an inhibitor of aminopeptidase A, produced by actinomycetes. J Antibiot (Tokyo) (1978) 1.03
Purification by affinity chromatography using amastatin and properties of aminopeptidase A from pig kidney. Biochim Biophys Acta (1980) 1.02
A -lactamase of Escherichia coli. Biochim Biophys Acta (1972) 1.02
Biological studies on individual bleomycins. J Antibiot (Tokyo) (1968) 1.02
Breaks and rejoining of DNA in cultured mammalian cells treated with bleomycin. Gan (1970) 1.02
Studies on the mechanism of antitumor effect of bleomycin of squamous cell carcinoma. J Antibiot (Tokyo) (1972) 1.01
Purification of bleomycins. J Antibiot (Tokyo) (1966) 1.01
Studies on marine microorganisms. V. A new antibiotic, aplasmomycin, produced by a streptomycete isolated from shallow sea mud. J Antibiot (Tokyo) (1976) 1.01
An enzyme inhibitor, panosialin, produced by Streptomyces. II. Chemistry of panosialin, 5-alkylbenzene-1,3-disulfates. J Antibiot (Tokyo) (1971) 1.00
The distribution of 3H-bleomycin in mouse tissue. J Antibiot (Tokyo) (1968) 0.99
Protease inhibitors produced by microorganisms. Acta Biol Med Ger (1977) 0.99
Chemistry of bleomycin. XXI. Metal-complex of bleomycin and its implication for the mechanism of bleomycin action. J Antibiot (Tokyo) (1978) 0.98
Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. I. Taxonomy, production, isolation and preliminary characterization. J Antibiot (Tokyo) (1986) 0.98
The combined effects of bleomycin and sulfhydryl compounds on the thermal denaturation of DNA. Biochim Biophys Acta (1969) 0.98
Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties. J Antibiot (Tokyo) (1979) 0.98
Isolation and properties of valanimycin, a new azoxy antibiotic. J Antibiot (Tokyo) (1986) 0.98
Structure of an antitumor antibiotic, spergualin. J Antibiot (Tokyo) (1981) 0.97
Chemistry of bleomycin. XX. The X-ray structure determination of P-3A Cu(II)-complex a biosynthetic intermediate of bleomycin. J Antibiot (Tokyo) (1978) 0.97
Novel antibiotics napyradiomycins. Production, isolation, physico-chemical properties and biological activity. J Antibiot (Tokyo) (1986) 0.97
Macarbomycin, an inhibitor of peptidoglycan synthesis. J Antibiot (Tokyo) (1972) 0.97
Suppression of tissue graft rejection by spergualin. J Antibiot (Tokyo) (1985) 0.97
Brain and physics of many-body problems. Kybernetik (1967) 0.97
Factors affecting infection of protoplasts with deoxyribonucleic acid of actinophage PK-66. J Virol (1968) 0.96
Studies on inhibitory effect of phosphoramidon and its analogs on thermolysin. Arch Biochem Biophys (1975) 0.96
Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. II. Structure of fatty acid residue and amino acid sequence. J Antibiot (Tokyo) (1986) 0.96
Studies on bleomycin: chemistry and the biological action. Biomedicine (1973) 0.96
Inhibition of RNA and DNA polymerase reactions by pluramycin A. Biochem Biophys Res Commun (1965) 0.96
Structure of antipain, a new Sakaguchi-positive product of streptomyces. J Antibiot (Tokyo) (1972) 0.95
New antibiotic napyradiomycins A2 and B4 and stereochemistry of napyradiomycins. J Antibiot (Tokyo) (1987) 0.95
Tetrahydropyranyl derivatives of daunomycin and adriamycin. J Antibiot (Tokyo) (1979) 0.94
The structural studies of formycin and formycin B. Tetrahedron Lett (1966) 0.94
Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. III. Structural elucidation of plipastatins. J Antibiot (Tokyo) (1986) 0.94
Letter: Elastatinal, a new elastase inhibitor produced by actinomycetes. J Antibiot (Tokyo) (1973) 0.94
The structure of bestatin. J Antibiot (Tokyo) (1976) 0.94
Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer. Arch Biochem Biophys (1976) 0.94
Bacillus cereus beta-lactamase. Reaction with N-bromosuccinimide and the properties of the product. Biochim Biophys Acta (1975) 0.94
Immunological studies of aminoglycoside 3'-phosphotransferases. J Antibiot (Tokyo) (1976) 0.94
Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria. J Antibiot (Tokyo) (1984) 0.94